최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기응용통계연구 = The Korean journal of applied statistics, v.33 no.2, 2020년, pp.137 - 145
전소영 (가톨릭대학교 의생명.건강과학과) , 김동재 (가톨릭대학교 의생명.건강과학과)
Phase I clinical trials (Dose Finding Studies) are the first step in administering new drugs developed through animal experiments or in vitro experiments to humans. An important area of interest in designing Phase I clinical trials is determining the dose that provides the greatest efficacy and acce...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Ahn, C. (1998). An evaluation of Phase I cancer clinical trial designs, Statistics in Medicine, 17, 1537-1549.
Chevret, S. (1993). The continual reassessment method in cancer phase I clinical trials: a simulation study, Statistics in Medicine, 12, 1093-1108.
Dixon, W. J. and Mode, A. M. (1948). A method for obtaining and analyzing sensitivity data, Journal of the American Statistical Association, 43, 109-128.
Efron, B. (1971). Forcing a sequential experiment to be balanced, Biometrika, 58, 403-417.
Goodman, S. N., Zahurak, M. L., and Piantadosi, S. (1995). Some practical improvements in the continual reassessment method for phase I studies, Statistics in Medicine, 14, 1149-1161.
Korn, E. L., Midthune, D., Chen, T. T., Rubinstein, L. V., Christian, M. C., and Simon, R. M. (1994). A comparison of two phase I trial designs, Statistics in Medicine, 13, 1799-1806.
Lee, N. and Kim, D. (2012). Two-stage maximum tolerated dose estimation by stopping rule in Phase I clinical trial, The Korean Statistical Society, 19, 57-64.
Lim, H. (2018). New Drug Development and Clinical Trials, Bullsbook.
O'Quigley, J. and Chevret, S. (1991). Method for dose finding studies in cancer clinical trials: a review and results of a Monte Carlo study, Statistics in Medicine, 10, 1647-1664.
O'Quigley, J., Pepe, M. and Fisher, M. (1990). Continual reassessment method: a practical design for phase I clinical trials in cancer, Biometrics, 46, 33-48.
O'Quigley, J. Shen, L.Z. (1996). Continual reassessment method: a likelihood approach , Biometrics, 52, 673-684.
Park, I. (1999). The estimation of maximal tolerated dose in sequential phase I clinical trials (Master's Thesis of Science), The Catholic University of Korea.
Storer, B. E. (1989). Design and analysis of phase I clinical trials, Biometrics, 45, 925-937.
Storer, B. E. (2001). An evaluation of phase I clinical trial designs in the continuous dose response setting, Statistics in Medicine, 20, 2399-2408.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.